PRESS & MEDIA
IndyGeneUS Expands its Biologics & Gene Target Discovery Capabilities with SanKav Pharmaceutical (CDMO) Partnership
IndyGeneUS | March 4, 2024
Innovative biotech company IndyGeneUS has announced a groundbreaking partnership with SanKav Pharmaceuticals, a leading provider of biopharmaceutical and cell & gene therapy analytics and manufacturing services. This strategic collaboration will significantly enhance IndyGeneUS’s drug discovery capabilities and pave the way for the development of advanced therapeutics to address health disparities impacting African and Hispanic diaspora populations.
Grand Opening
SanKav Pharmaceuticals | January 9, 2023
On January 9, 2023, SanKav Pharmaceuticals officially opened its doors to start offering services in R&D, manufacturing, packaging, and analytical testing services.
The program of the day included statements from CEO and founder Sanjeev K. Gupta, guests of honor Assemblywomen Aura K. Dunn, Washington Township Mayor Matthew Murello, and Morris County Commissioner Director John Krickus. Attendees all received a site tour and finished the day with a presentation on Essential Medicines & Biotech.
Biopharma resilience: CDMOs secure supply chain management
Cytiva | November 16, 2022
Learn how SanKav Pharmaceuticals delivers medicine to market through available components, resources and raw materials that support on-time production lines and biomanufacturing processes.
